These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 32256474)
1. Ultra-Short Antimicrobial Peptoids Show Propensity for Membrane Activity Against Multi-Drug Resistant Khara JS; Mojsoska B; Mukherjee D; Langford PR; Robertson BD; Jenssen H; Ee PLR; Newton SM Front Microbiol; 2020; 11():417. PubMed ID: 32256474 [TBL] [Abstract][Full Text] [Related]
2. Novel tetrameric cell penetrating antimicrobial peptoids effective against mycobacteria and drug-resistant Fleck BS; Mukherjee D; Tram NDT; Ee PLR; Schepers U Front Biosci (Landmark Ed); 2022 Feb; 27(2):64. PubMed ID: 35227007 [TBL] [Abstract][Full Text] [Related]
3. Unnatural amino acid analogues of membrane-active helical peptides with anti-mycobacterial activity and improved stability. Khara JS; Priestman M; Uhía I; Hamilton MS; Krishnan N; Wang Y; Yang YY; Langford PR; Newton SM; Robertson BD; Ee PL J Antimicrob Chemother; 2016 Aug; 71(8):2181-91. PubMed ID: 27118774 [TBL] [Abstract][Full Text] [Related]
4. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
5. Designing α-helical peptides with enhanced synergism and selectivity against Mycobacterium smegmatis: Discerning the role of hydrophobicity and helicity. Khara JS; Lim FK; Wang Y; Ke XY; Voo ZX; Yang YY; Lakshminarayanan R; Ee PLR Acta Biomater; 2015 Dec; 28():99-108. PubMed ID: 26380930 [TBL] [Abstract][Full Text] [Related]
6. Allicin enhances antimicrobial activity of macrophages during Mycobacterium tuberculosis infection. Dwivedi VP; Bhattacharya D; Singh M; Bhaskar A; Kumar S; Fatima S; Sobia P; Kaer LV; Das G J Ethnopharmacol; 2019 Oct; 243():111634. PubMed ID: 30537531 [TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
8. Tachyplesin and CyLoP-1 as efficient anti-mycobacterial peptides: A novel finding. Priya A; Aditya A; Budagavi DP; Chugh A Biochim Biophys Acta Biomembr; 2022 Jul; 1864(7):183895. PubMed ID: 35271828 [TBL] [Abstract][Full Text] [Related]
9. FDA-Approved Amoxapine Effectively Promotes Macrophage Control of Mycobacteria by Inducing Autophagy. Wang J; Sha J; Strong E; Chopra AK; Lee S Microbiol Spectr; 2022 Oct; 10(5):e0250922. PubMed ID: 36129262 [TBL] [Abstract][Full Text] [Related]
10. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms. Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059 [TBL] [Abstract][Full Text] [Related]
12. Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin. Khara JS; Wang Y; Ke XY; Liu S; Newton SM; Langford PR; Yang YY; Ee PL Biomaterials; 2014 Feb; 35(6):2032-8. PubMed ID: 24314557 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of peptoid mimics of short, lipophilic peptide antimicrobials. Green RM; Bicker KL Int J Antimicrob Agents; 2020 Aug; 56(2):106048. PubMed ID: 32540430 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of tetracycline analogs against multidrug-resistant and extensive drug resistance clinical isolates of Mycobacterium tuberculosis. Zhang C; Ouyang Q; Zhou X; Huang Y; Zeng Y; Deng L; Lin D; Zheng W Tuberculosis (Edinb); 2023 May; 140():102336. PubMed ID: 36963294 [TBL] [Abstract][Full Text] [Related]
15. Helicity Modulation Improves the Selectivity of Antimicrobial Peptoids. Nam HY; Choi J; Kumar SD; Nielsen JE; Kyeong M; Wang S; Kang D; Lee Y; Lee J; Yoon MH; Hong S; Lund R; Jenssen H; Shin SY; Seo J ACS Infect Dis; 2020 Oct; 6(10):2732-2744. PubMed ID: 32865961 [TBL] [Abstract][Full Text] [Related]
16. Characterization of novel antimicrobial peptoids. Goodson B; Ehrhardt A; Ng S; Nuss J; Johnson K; Giedlin M; Yamamoto R; Moos WH; Krebber A; Ladner M; Giacona MB; Vitt C; Winter J Antimicrob Agents Chemother; 1999 Jun; 43(6):1429-34. PubMed ID: 10348765 [TBL] [Abstract][Full Text] [Related]
17. Anti-mycobacterial peptides: from human to phage. Teng T; Liu J; Wei H Cell Physiol Biochem; 2015; 35(2):452-66. PubMed ID: 25613372 [TBL] [Abstract][Full Text] [Related]
18. [Prospects for development of new antituberculous drugs]. Tomioka H Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850 [TBL] [Abstract][Full Text] [Related]
19. Cationic amphipathic D-enantiomeric antimicrobial peptides with in vitro and ex vivo activity against drug-resistant Mycobacterium tuberculosis. Lan Y; Lam JT; Siu GK; Yam WC; Mason AJ; Lam JK Tuberculosis (Edinb); 2014 Dec; 94(6):678-89. PubMed ID: 25154927 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of collinin isolated from the leaves of Zanthoxylum schinifolium against multidrug- and extensively drug-resistant Mycobacterium tuberculosis. Kim S; Seo H; Mahmud HA; Islam MI; Lee BE; Cho ML; Song HY Phytomedicine; 2018 Jul; 46():104-110. PubMed ID: 30097109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]